Tolerance and efficacy in monotherapy of CLEANANCE COMEDOMED localized drying emulsion - Comparative study in hemifacial application

Tolerance and efficacy of CLEANANCE COMEDOMED localized drying care as monotherapy in adults with inflammatory facial acne, under dermatological control

Comparative hemi-face study

Population

16 subjects aged 18 to 31 with inflammatory facial acne (at least 2 recent and comparable inflammatory lesions on each hemiface)

Application of CLEANANCE COMEDOMED localized drying emulsion

3 applications per day on inflammatory lesions on half the face for 2 weeks

Evaluation criteria

Clinical grading of the severity of inflammatory lesions (Score from -1= worsening to 4= very good improvement)
Skin tolerance

Results

Improvement in the severity of inflammatory lesions as early as D2, compared with the untreated hemiface: 37.5% of subjects improved versus 0% for the untreated hemiface

Evolution of inflammatory lesion severity (clinical score) over 2 weeks, versus untreated hemiface

Good skin tolerance

Conclusion

CLEANANCE COMEDOMED localized drying emulsion applied three times a day demonstrated an improvement in the severity of inflammatory lesions as early as 1 day of application, compared to an untreated control

Good skin tolerance and excellent ocular tolerance

Acne

Efficacy and tolerability of KERACNYL serum in mild to moderate adult female acne

DUCRAY

Acne
Pediatrics

Tolerance and efficacy of KERACNYL Foaming Gel

DUCRAY

Tolerance and efficacy of KERACNYL Foaming Gel in combination with topical and oral acne treatments, under dermatological control

Acne
Pediatrics

Tolerance and efficacy of KERACNYL UV+ anti-blemish fluid

DUCRAY

Tolerance and efficacy of KERACNYL UV+ anti-blemish fluid in subjects with mild to moderate acne, under dermatological and ophthalmological control

Summary of clinical results